Welcome to our dedicated page for Accolade news (Ticker: ACCD), a resource for investors and traders seeking the latest updates and insights on Accolade stock.
Accolade, Inc. reports developments for its personalized healthcare platform, which combines virtual primary care, mental health support, expert medical opinion services, and care navigation for employer, health plan, and consumer markets. Company updates often center on PlushCare, direct-to-consumer virtual healthcare access, Medicare Part B acceptance, and services aimed at primary care, clinical weight management, and behavioral health support.
Recurring ACCD news also covers operating and financial results, investor presentations, material agreements, shareholder voting matters, governance, capital-structure disclosures, and healthcare regulatory topics tied to Accolade's virtual care and navigation model.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Accolade, Inc. (NASDAQ: ACCD) has announced its upcoming Analyst Day event scheduled for May 8, 2023, at the Wynn Las Vegas. The event will start at 1pm PT and will be available via a live webcast for pre-registered attendees. During the event, Accolade’s management will share insights into the company’s long-term vision, along with details on its product, clinical, ecosystem, and financial strategies. Interested participants can register through ir.accolade.com. A replay of the event will also be accessible after the live session.
Accolade focuses on providing personalized healthcare solutions to millions, ensuring high consumer satisfaction ratings exceeding 90%. For more information, visit accolade.com.
Accolade, Inc. (NASDAQ: ACCD) announced that it will release its fiscal fourth quarter 2023 financial results on April 27, 2023, after market close. A conference call will follow at 4:30 p.m. E.T. to discuss the results.
The call will be accessible via telephone or internet, with pre-registration required for the phone option. A replay will be available shortly after the call concludes. Accolade specializes in personalized healthcare solutions, enhancing healthcare experiences for millions through virtual primary care, mental health services, and care navigation.
The company consistently achieves over 90% consumer satisfaction ratings, reflecting its commitment to improving healthcare delivery.
Accolade, Inc. (Nasdaq: ACCD) has partnered with Lyra Health to enhance behavioral health care access for employers. This collaboration, part of Accolade's Trusted Partner Ecosystem, aims to address the barriers faced by U.S. workers in accessing mental health services. A recent Gallup survey revealed over half of workers lack awareness of available resources. Lyra Health provides evidence-based services, aiming for prompt access with an average wait time of only two days for appointments. The partnership promises improved mental health support for joint customers without additional costs.